Corrigendum to Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Bode B, Garrett V, Messler J, et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States [published online ahead of print May, 09, 2020]. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820924469

Two numeric values in Table 1 were incorrect in the previous published version. The correct values are bold in the table below, and the online file has been corrected.

Table 1.

Demographic and Clinical Characteristics of 1122 Hospitalized COVID-19 Patients, Comparing Presence (n=451) Versus Absence (n=671) of Diabetes or Uncontrolled Hyperglycemia.

Variable	+ Diabetes and/or Uncontrolled Hyperglycemia(n=451)	- Diabetes or Uncontrolled Hyperglycemia(n=671)	p-value
Patients, n (%)	451 (40.2)	671 (59.8)
Male Gender, n (%)	268 (59.4)	356 (53.1)	0.035
Median Age in years (range)	65 (24-95)	61 (18-101)	0.005
Mean BMI, kg/m2 (SD)	31.8 (±13)	30.8 (±15)	0.053
Mean A1C, % (SD) a	8.7 (±2.4)	5.8 (±0.4)	<0.001
Diabetes by A1C criteria, n (%)	194 (17.3)	0 (0.0)

Abbreviations: BMI, body mass index; SD, standard deviation.

a

A1C was available in 221 of 451 diabetes and/or uncontrolled hyperglycemia patients (49.0%) and in 61 of 671 patients without diabetes or uncontrolled hyperglycemia (9.1%).